BAseLine TEstosterone as a Prognostic and/or Predictive bioMARKer in mHSPC

Clinical trial NCT05530395 · UNKNOWN

Trial details

NCT number: NCT05530395
Sponsor: Ignacio Puche Sanz
Status: UNKNOWN
Study type: OBSERVATIONAL

Prostate Cancer Metastatic

Start date: 2023-01-01
Primary completion: 2025-01-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.